The FDA has approved daratumumab and hyaluronidase-fihj in combination with other therapies as first-line treatment for certain patients with multiple myeloma. The U.S. Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj (Darzalex Faspro)...
A vaccine helps reduce recurrences in melanoma, and a blood test may predict which small cell lung cancer patients will respond to immunotherapy.
Cancer Today's winter 2025-2026 issue covers delaying stem cell transplants in multiple myeloma, new treatments for brain metastases, and more.
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
Government cuts to research limit options for children with rare cancers, and a study links exercise with lower fatigue for people with colorectal cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
ctDNA status may also inform treatment plan. Breast cancer is the most common form of non-skin cancer in the United States, and human epidermal growth factor receptor 2-positive breast cancer, or HER2-positive breast cancer,...
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
Recently updated federal guidelines for cervical cancer screening and the HPV vaccine could make these prevention strategies more convenient.
Guidelines now recommend self-administered HPV tests for cervical cancer screening, and adding megestrol to hormone therapy slows tumor growth.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More